Literature DB >> 9573078

Nasopharyngeal colonization with nontypeable Haemophilus influenzae in chinchillas.

Y P Yang1, S M Loosmore, B J Underdown, M H Klein.   

Abstract

Colonization of the nasopharynx by a middle ear pathogen is the first step in the development of otitis media in humans. The establishment of an animal model of nasopharyngeal colonization would therefore be of great utility in assessing the potential protective ability of candidate vaccine antigens (especially adhesins) against otitis media. A chinchilla nasopharyngeal colonization model for nontypeable Haemophilus influenzae (NTHI) was developed with antibiotic-resistant strains. This model does not require coinfection with a virus. There was no significant difference in the efficiency of NTHI colonization between adult (1- to 2-year-old) and young (2- to 3-month-old) animals. However, the incidence of middle ear infection following nasopharyngeal colonization was significantly higher in young animals (83 to 89%) than in adult chinchillas (10 to 30%). Chinchillas that had recovered either from a previous middle ear infection caused by NTHI or from an infection by intranasal inoculation with NTHI were completely protected against nasopharyngeal colonization with a homologous strain and were found to be the best positive controls in protection studies. Systemic immunization of chinchillas with inactivated whole-cell preparations significantly protected animals not only against homologous NTHI colonization but also partially against heterologous NTHI infection. In all protected animals, significant serum anti-P6 and anti-HMW antibody responses were observed. The outer membrane P6 and high-molecular-weight (HMW) proteins appear to be promising candidate vaccine antigens to prevent nasopharyngeal colonization and middle ear infection caused by NTHI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573078      PMCID: PMC108152          DOI: 10.1128/IAI.66.5.1973-1980.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Interaction of rabbit secretory component with rabbit IgA dimer.

Authors:  L C Kühn; J P Kraehenbuhl
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Secretory component as the mucosal transport receptor: separation of physicochemically analogous human IgA fractions with different receptor-binding capacities.

Authors:  J M Schiff; M M Fisher; B J Underdown
Journal:  Mol Immunol       Date:  1986-01       Impact factor: 4.407

4.  The nasopharyngeal microflora of otitis-prone children, with emphasis on H. influenzae.

Authors:  A Freijd; S Bygdeman; B Rynnel-Dagöö
Journal:  Acta Otolaryngol       Date:  1984 Jan-Feb       Impact factor: 1.494

5.  Outer membrane protein and biotype analysis of pathogenic nontypable Haemophilus influenzae.

Authors:  S J Barenkamp; R S Munson; D M Granoff
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.

Authors:  Y P Yang; R S Munson; S Grass; P Chong; R E Harkness; L Gisonni; O James; Y Kwok; M H Klein
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

7.  Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.

Authors:  H E Gnehm; S I Pelton; S Gulati; P A Rice
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system.

Authors:  T F Murphy; M A Apicella
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens.

Authors:  R B Karasic; C E Trumpp; H E Gnehm; P A Rice; S I Pelton
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

10.  Identification of a specific epitope of Haemophilus influenzae on a 16,600-dalton outer membrane protein.

Authors:  T F Murphy; M B Nelson; K C Dudas; J M Mylotte; M A Apicella
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

View more
  6 in total

1.  Development and characterization of a Staphylococcus aureus nasal colonization model in mice.

Authors:  K B Kiser; J M Cantey-Kiser; J C Lee
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae.

Authors:  J U Igietseme; J L Portis; L L Perry
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.

Authors:  B J Kennedy; L A Novotny; J A Jurcisek; Y Lobet; L O Bakaletz
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models.

Authors:  Wenzhou Hong; Daxin Peng; Maritza Rivera; Xin-Xing Gu
Journal:  Microbes Infect       Date:  2009-09-24       Impact factor: 2.700

Review 5.  New paradigms in the pathogenesis of otitis media in children.

Authors:  James Mark Coticchia; Michael Chen; Livjot Sachdeva; Sean Mutchnick
Journal:  Front Pediatr       Date:  2013-12-23       Impact factor: 3.418

6.  Haemophilin-Producing Strains of Haemophilus haemolyticus Protect Respiratory Epithelia from NTHi Colonisation and Internalisation.

Authors:  Brianna Atto; Dale Kunde; David A Gell; Stephen Tristram
Journal:  Pathogens       Date:  2021-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.